August 09, 2019
A New Jersey federal judge Friday rejected Sandoz Inc.'s attempt to invalidate two patents covering Amgen subsidiary Immunex Corp.'s blockbuster immunosuppressant Enbrel, stalling Sandoz's aim to launch a biosimilar version of the drug.
June 21, 2017
A Nobel Prize-winning researcher has moved to block a Sandoz Inc. subpoena seeking testimony related to a biosimilar of Amgen Inc.'s blockbuster immunosuppressant Enbrel, telling a Texas federal court that the deposition would almost certainly be fruitless.